So they pay this dude to try and persuade the decisions of government regarding Alzheimer's. That's fresh. 
Biogen’s head-scratching new lobbyist hire
Biogen’s head-scratching new lobbyist hire
-
Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page
Biogen Hires A Lobbyist. Another Very Desperate Move.
- Thread starter anonymous
- Start date
-
- Tags
- None
So they pay this dude to try and persuade the decisions of government regarding Alzheimer's. That's fresh.
Biogen’s head-scratching new lobbyist hire
Yep. One of gov’t affairs’ priorities is to elevate getting CMS coverage for all FDA approved drugs as a congressional issue. As long ad they give me my severance, I don’t care what they do anymore,
Why are you on here if you don’t like the whining?
Good luck getting one agency to dictate the policy of another, especially in the context of Adu. CMS is in the right and the FDA is in the wrong. Maybe we should figure out why the neuroscience head forced approval of a drug based on a surrogate marker when no Clincial benefit was established, their expert subcommittee was overwhelmingly against it, and the drug was priced like an orphan drug despite 2-3 million candidates in the Medicare patient population.
Connect the dots. They’re going to play the race card. In for a penny, in for a pound.
It is a desperate attempt. Even still, a lawsuit will have to come from a patient and you are looking at a year or more.